RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/27927647http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/27927647http://www.w3.org/2000/01/rdf-schema#comment"Allogeneic bone marrow transplantation (allo-BMT) is a curative therapy for hematological malignancies, but is associated with significant complications, principally graft-versus-host disease (GVHD) and opportunistic infections. Natural killer (NK) cells mediate important innate immunity that provides a temporal bridge until the reconstruction of adaptive immunity. Here, we show that the development of GVHD after allo-BMT prevented NK-cell reconstitution, particularly within the maturing M1 and M2 NK-cell subsets in association with exaggerated activation, apoptosis, and autophagy. Donor T cells were critical in this process by limiting the availability of interleukin 15 (IL-15), and administration of IL-15/IL-15Rα or immune suppression with rapamycin could restore NK-cell reconstitution. Importantly, the NK-cell defect induced by GVHD resulted in the failure of NK-cell-dependent in vivo cytotoxicity and graft-versus-leukemia effects. Control of cytomegalovirus infection after allo-BMT was also impaired during GVHD. Thus, during GVHD, donor T cells compete with NK cells for IL-15 thereby inducing profound defects in NK-cell reconstitution that compromise both leukemia and pathogen-specific immunity."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.org/dc/terms/identifier"doi:10.1182/blood-2016-08-734020"xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Lane S.W."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Bunting M.D."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Smyth M.J."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Blazar B.R."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Degli-Esposti M.A."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Hill G.R."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Tey S.K."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Huntington N.D."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Lineburg K.E."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Fleming P."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"MacDonald K.P."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Varelias A."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Kuns R.D."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Souza-Fonseca-Guimaraes F."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Schuster I.S."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/author"Locke K.R."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/pages"630-642"xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/title"GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity."xsd:string
http://purl.uniprot.org/citations/27927647http://purl.uniprot.org/core/volume"129"xsd:string
http://purl.uniprot.org/citations/27927647http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/27927647